Trial Profile
Ibudilast in the Treatment of Medication Overuse Headache: A Double-blind, Randomised, Placebo-controlled Pilot Study.
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Ibudilast (Primary)
- Indications Secondary headache disorders
- Focus Therapeutic Use
- 05 Feb 2013 Planned end date changed from 1 Dec 2011 to 1 Aug 2013 as reported by ClinicalTrials.gov.
- 13 Mar 2012 This trial is ongoing, according to a MediciNova media release.
- 26 Oct 2011 Trial phase changed from I to I/II as reported by ClinicalTrials.gov.